SHISEIDO COMPANY LIMITED | 11,531 Euro | +0,124 +1,09 % | |
| WKN: 854002 ISIN: JP3351600006 Ticker-Symbol: SHD | Frankfurt | 19.06.13 | 15:32 Uhr |
Branche KosmetikAktienmarkt NIKKEI-225 |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 10.06. | Sodium Hyaluronate (HA) by Shiseido (CAS 9067-32-7) Market Research Report 2013 | 40 | PR Newswire | |
| DUBLIN, Ireland, June 10, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/4nb46z/sodium) has announced the addition of the "Sodium Hyaluronate (HA) by Shiseido... Mehr lesen zu: Sodium Hyaluronate (HA) by Shiseido (CAS 9067-32-7) Market Research Report 2013 | ||||
| 04.06. | Kosmetik-Riese Shiseido investiert über 30 Mio. in diese Firma mit revolutionärer Haarwuchs-Technologie! | 150 | börsennews.de | |
| Das Unternehmen habe unter der Leitung des deutschen Wissenschaftlers Prof. Dr. Rolf Hoffmann eine patentierte Technologie entwickelt, mit welcher auf kahlen Köpfen wieder Haare wachsen würden. Die... Mehr lesen zu: Kosmetik-Riese Shiseido investiert über 30 Mio. in diese Firma mit revolutionärer Haarwuchs-Technologie! | ||||
| 29.05. | Shiseido Licenses Hair Regeneration Method From Canada Firm | 3 | Nikkei.com | |
| 29.05. | RepliCel und Shiseido verkünden Zusammenarbeit und Rahmenvereinbarung über Technologietransfer sowie exklusive geografische Technologielizenz | 49 | boerse-express.com | |
| 29.05. | IRW-PRESS: RepliCel Life Sciences Inc.: RepliCel und Shiseido verkünden Zusammenarbeit und Rahmenvereinbarung über Technologietransfer sowie exklusive geografische Technologielizenz | 239 | dpa-AFX | |
| IRW-PRESS: RepliCel Life Sciences Inc.: RepliCel und Shiseido
verkünden Zusammenarbeit und Rahmenvereinbarung über
Technologietransfer sowie exklusive geografische Technologielizenz
RepliCel... Mehr lesen zu: IRW-PRESS: RepliCel Life Sciences Inc.: RepliCel und Shiseido verkünden Zusammenarbeit und Rahmenvereinbarung über Technologietransfer sowie exklusive geografische Technologielizenz | ||||
| 29.05. | RepliCel Life Sciences Inc: RepliCel to license hair-regeneration tech to Shiseido | 3 | Stockwatch | |
| 29.05. | Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License | 60 | Marketwired | |
| TOKYO, JAPAN and VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/29/13 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF)(CNSX: RP) and Shiseido Company, Limited ("Shiseido")... Mehr lesen zu: Replicel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License | ||||
| 13.05. | Update-Moody's downgrades Shiseido to A2; negative outlook | 5 | Reuters.com | |
| 26.04. | Shiseido Said to Consider Dividend Cut After Posting Net Loss | 13 | Bloomberg | |
| 25.04. | Shiseido falls into red on write-down | 4 | The Star | |
| 25.04. | Shiseido Drops After Unexpected Net Loss Forecast: Tokyo Mover | 3 | Bloomberg | |
| 24.04. | Shiseido Forecasts First Loss in Eight Years on Bare Escentuals | 4 | Bloomberg | |
| 27.03. | XFRA DIVIDEND INFORMATION - 27.03.2013 - 10 | 440 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 27.03.2013 EX DIVIDENDE GEHANDELT.
THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 27.03.2013.
INSTR EXCH ISIN INSTRUMENT NAME REF.PRC ADJUST
RL2 XFRA JP3409000001... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 27.03.2013 - 10 | ||||
| 12.03. | Maeda wird wieder Shiseido-Firmenchef | 20 | FashionUnited | |
| 11.03. | Cosmetics maker Shiseido's president to step down by March | 4 | Japan Daily Press | |
| 11.03. | Shiseido president to step down | 2 | Irish Times | |
| 11.03. | UPDATE 1-Cosmetics giant Shiseido president to exit, shares jump | 1 | Reuters.com | |
| 11.03. | Cosmetics giant Shiseido set to replace president, shares jump | - | Reuters.com | |
| 11.03. | Shiseido President Suekawa Said to Step Down | - | Bloomberg | |
| 04.03. | Sodium Hyaluronate (HA) by Shiseido (CAS 9067-32-7) Market Reviewed by BAC in Discounted Report Available at MarketPublishers.com | 91 | Business Wire | |
| Shiseido (based in Japan) initiated the production of sodium hyaluronate
in the mid 1980-s. Its original manufacturing process is based on
fermentation without involving... Mehr lesen zu: Sodium Hyaluronate (HA) by Shiseido (CAS 9067-32-7) Market Reviewed by BAC in Discounted Report Available at MarketPublishers.com | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| LOREAL | 128,17 | +0,28 % | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 12.06.2013: ADIDAS, ALLIANZ, BALDA, BAYER, BMW, COMMERZBANK, CONTINENTAL, DAIMLER, DEUTSCHE TELEKOM, DEUTZ, EADS, ENEL, E.ON, FRAPORT, FREENET, GENERALI, ... |
| BEIERSDORF | 67,74 | -0,03 % | dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 14.06.2013: LUFTHANSA, RWE, VOLKSWAGEN, BMW, DAIMLER, DIALOG SEMICONDUCTOR, ENEL, RHOEN-KLINIKUM, CONTINENTAL, FRAPORT, GOOGLE, CTS EVENTIM, HEIDELBERGER ... |
| ESTEE LAUDER | 52,05 | -1,09 % | Estée Lauder Names Michael O'Hare As EVP, Global Human Resources |
| CLOROX | 64,05 | -0,69 % | The Clorox Company Presents at DbAccess 10th Annual Global Consumer Conference, Jun-12-2013 11:15 AM |
| LOCCITANE INTERNATIONAL | 1,999 | -0,55 % | Nomura lowers L'Occitane (00973) to HK$24.5 |
